3SBio (FRA:83B) FCF Yield % : 9.24 (As of May. 05, 2024)

View and export this data going back to 2015. Start your Free Trial

What is 3SBio FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, 3SBio's Trailing 12-Month Free Cash Flow is €177 Mil, and Market Cap is €1,945 Mil. Therefore, 3SBio's FCF Yield % for today is 9.24%.

The historical rank and industry rank for 3SBio's FCF Yield % or its related term are showing as below:

FRA:83B' s FCF Yield % Range Over the Past 10 Years
Min: 1.42 Med: 2.49 Max: 12.45
Current: 9.24

During the past 10 years, the highest FCF Yield % of 3SBio was 12.45%. The lowest was 1.42%. And the median was 2.49%.

FRA:83B's FCF Yield % is ranked better than
97.55% of 1553 companies
in the Biotechnology industry
Industry Median: -14.39 vs FRA:83B: 9.24

3SBio's FCF Margin % for the quarter that ended in Dec. 2023 was 13.89%.

3SBio FCF Yield % Historical Data

The historical data trend for 3SBio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio FCF Yield % Chart

3SBio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

6.00

2.42

3.47

6.25

8.84

3SBio Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															2.43	10.88	4.91	9.94	7.18

Competitive Comparison of 3SBio's FCF Yield %

For the Biotechnology subindustry, 3SBio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3SBio's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where 3SBio's FCF Yield % falls into.

3SBio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

3SBio's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	177.041	/	2002.7976
	=	8.84%

3SBio's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	71.933	*	2	/	2002.7976
	=	7.18%

3SBio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

3SBio FCF Yield % Related Terms

Thank you for viewing the detailed overview of 3SBio's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio (FRA:83B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (FRA:83B) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

01530:Hong Kong 83B:Germany

Address

No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027

Website

https://www.3sbio.com

3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

3SBio (FRA:83B) Headlines

No Headlines